Insight on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Report
Report

Epidemiology: Allergic Rhinitis - Allergic rhinitis is highly prevalent yet significantly under-diagnosed

Overview of allergic rhinitis definition and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent forecast, and key patient segments across the seven major markets.

Published By Datamonitor
05 Apr 2011 $2800
Buy
Report
Report

R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy

Progress in sepsis drug development has been severely hindered by the complex disease pathogenesis and patient heterogeneity. This module reviews pipeline trends, clinical trial design, and future treatment paradigms for sepsis.

Published By Datamonitor
06 Apr 2011 $2800
Buy
Report
Report

Epidemiology: Insomnia - The growing elderly population will result in increasing prevalence

Overview of insomnia definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
07 Apr 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview

Analysis of socio-demographic and economic trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
13 Apr 2011 $1520
Buy
Report
Report

Pharmaceutical Key Trends 2011: Generics Market Overview

Analysis on the global generics market. It includes an overview of drivers and resistors to generic uptake, key generics players, and opportunities for the generics industry.

Published By Datamonitor
18 Apr 2011 $2800
Buy
Report
Report

R&D Trends: Multiple Sclerosis - Progressive subtypes remain underserved in expansive pipeline

Review of key trends in the development of new MS drugs across the seven major markets. Also includes detailed analyses of clinical trial design, target product profile, innovative early-stage projects and future treatment developments.

Published By Datamonitor
26 Apr 2011 $2800
Buy
Report
Report

R&D Trends: Obesity - 2006–2011: obesity’s lean years

Datamonitor module assesses the current state of the obesity pipeline and trends that will shape its future. Focused on the US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
11 May 2011 $2800
Buy
Report
Report

R&D Trends: Insulin Antidiabetics - The future is analogs

Datamonitor module assesses the current state of the insulin antidiabetics pipeline and trends in clinical trial design and treatment that will shape its future. Focused on the US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
11 May 2011 $2800
Buy
Report
Report

Epidemiology: Major Orthopedic Surgery – On the rise as the global elderly population continues to grow

Overview of major orthopedic surgery definition and review of the epidemiology literature. This report provides in-depth analysis of patient populations and a 10-year forecast of major orthopedic surgery, a major risk factor for pulmonary embolism.

Published By Datamonitor
12 May 2011 $2800
Buy
Report
Report

Case Study: Sepsis - Xigris’ disappointing performance creates a market opportunity for improved sepsis therapies

The Surviving Sepsis Campaign has created an increased focus on reducing levels of mortality from sepsis. Eli Lilly/BioCritica’s Xigris has been unable to capitalize on what remains a potentially lucrative therapy area with significant unmet needs.

Published By Datamonitor
17 May 2011 $1520
Buy

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.